AIDS WEEKLY Plus - December 2002Important note: Information in this article was accurate in December 2002. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

HIV/AIDS Pathogenesis: CD4 cell activation state linked to viral coat protein signaling ability

AIDSWEEKLY Plus; December 9, 2002
Michael Greer, Senior Medical Writer


NewsRx -- Researchers in the United States and Europe have shed new light on memory T cells' role in the early stages of HIV infection.

"The capacity of the HIV-1 envelope glycoprotein gp120 to induce intracellular signals is thought to contribute to HIV-1 pathogenesis," according to Sandrina Kinet and colleagues at the National Center for Scientific Research in Montpellier, France and the University of Iowa in Iowa City.

These virus-induced signals could be transmitted by activated CD4 cells, but not by their quiescent counterparts, Kinet and coauthors found.

CD4 cells prestimulated through the T-cell receptor (TCR) set off the mitogen-activated protein kinase (MAPK) signaling cascade after binding to gp120, the researchers said. The MAPK signaling pathway remained closed when gp120 bound to quiescent or nonproliferating cells, however, despite normal gp120 receptor expression by these cells.

TCR-stimulated T cells upregulated GM1, a ganglioside that marks the presence of lipid rafts, according to the report. Other studies have found evidence that glycosphingolipids in raft microdomains can facilitate HIV-cell fusion, essentially acting as HIV coreceptors like CXCR4 and CD4.

Interfering with viral lipid raft activity suppressed gp120-induced MAPK signaling (gp120-Mediated induction of the MAPK cascade is dependent on the activation state of CD4+ lymphocytes. Blood 2002 Oct 1;100(7):2546-53.

"Thus, stimulation of a mitogenic pathway by gp120 appears to require receptor binding in the context of membrane microdomains," Kinet and colleagues concluded. "These studies reveal a mechanism via which gp120 may differentially modulate the fate of activated and quiescent T cells in vivo."

The corresponding author for this report is Naomi Taylor, Institut de Genetique Moleculaire de Montpellier, CNRS UMR 5535, IFR 22, 1919 route Mende, F-34293 Montpellier 5, France. E-mail: taylor@jones.igm.cnrs-mop.fr.

Key points reported in this study include:

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Kinet S, Bernard F, Mongellaz C, et al., "gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes", Blood 2002 Oct 1;100(7):2546-53

021209
AW021204


Copyright © 2002 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.